Science

This can be a short description about this vertical and all the great links contained therein.

R&D Strategy

Evidence

Pipeline

Clinical Trials

Article originally published February 2026 […]

Learn More ›

Products

This can be a short description about this vertical and all the great links contained therein.

Sepsis ImmunoScore®

First-ever FDA authorized AI sepsis diagnostic tool with powerful diagnostic and predictive capabilities

5th World Sepsis Congress  |  […]

Learn More ›

Resources

This can be a short description about this vertical and all the great links contained therein.

Resource Library

Events

Sepsis ImmunoScore® demonstrates stronger predictive […]

Learn More ›

Newsroom

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Newsroom

Sepsis ImmunoScore® demonstrates stronger predictive […]

Learn More ›

About

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Mission, Vision, Values

Careers

Leadership

Awards

AI in Chicago  |  Episode […]

Learn More ›

Bobby Reddy, Jr. Discusses the Transformative Impact of AI on Sepsis Care–NewsNation Now

Bobby Reddy, Jr., Co-founder and CEO of Prenosis, appeared live on NewsNation Now for an in-depth, one-on-one interview about the transformative role of artificial intelligence in sepsis care. Airing just days after the FDA authorized the Sepsis ImmunoScore™, the discussion highlighted how this groundbreaking tool is revolutionizing acute care. NewsNation Now is a nationally broadcast news platform, reaching millions of viewers across the United States.